customer service software

Global Biopharmaceuticals Market

  • Published Date: 16 Oct 2018
  • Number of Pages: 173
  • Category: Healthcare and Medical
  • Country: Global
Biopharmaceuticals are medical drugs produced using biotechnology. Unlike the conventional pharmaceutical which is a chemical synthesis, biopharmaceuticals are proteins or nucleic acids that are produced by means other than direct extraction from a native biological source. The biopharmaceutical industry is a sunshine industry, radically new concepts are making to the market, such as cell therapy Provenge, which is used to treat cancer, and gene therapies which offer the promise of regenerative medicine and disease remission. Investing in biotech R&D has yielded better returns than the pharmaceutical industry average. The number of biotechnology patents applied for every year has been growing at 25 percent annually since 1995. Enhanced efficacy and low side effect has led to the growing preference of biopharmaceuticals over conventional pharmaceuticals.

Market Dynamics

The biopharmaceuticals generate global revenues of $163 billion, making up about 20 percent of the pharmaceuticals market. It is the fastest growing part of the pharmaceutical industry with annual growth of more than 8 percent, double that of conventional pharmaceuticals. Their ability to address previously untreatable conditions allows companies to command high prices for the drugs. Strong demand has driven significant profits, despite the high cost of goods sold.

The transition of biopharmaceuticals from the laboratory to market is paved with challenges of maintaining competitiveness by ensuring affordability, quality, and delivery performance. There are also operational and technical challenges, as reproducing large molecules reliably at an industrial scale requires manufacturing capabilities of high sophistication.
In the coming years, disruptive innovation such as immunotherapy, antibody drug conjugates, and gene and cell therapy will make progress toward commercial launch.

Market Segmentation

The biopharmaceutical market can be segmented on product basis -gene and cell therapy, cytokines, PEH (proteins, enzymes, hormones), monoclonal antibodies, vaccines, blood and allergenic components, and other.
Regional/Geographic Analysis
The United States accounts for nearly half of the global sales of biopharmaceuticals. The United States also accounts for more than 50 percent of investment in research and development in biopharmaceuticals. In recent years, countries like India and China have become favored destinations for biopharmaceuticals. With increase in affordability, the biopharmaceutical market will expand as there will be demand from Asia and Africa.

Key Players

Pfizer, Inc., F. Hoffmann-La Roche AG., Johnson & Johnson Services, Inc., Sanofi, Amgen Inc., Bayer AG.

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe

> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe

> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage

Publisher Name : Market Litmus

Global sarcopenia treatment market is valued approximately USD 2208.4 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period

View Report

The global market size of Skull Operating Rack is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit -

Cick Here